The emerging therapy of this peptide represents a exciting development in the management of type 2 diabetes. Distinct from existing medications, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide368207.kylieblog.com/42616807/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment